Lindsay Rosenwald
About Lindsay Rosenwald
Lindsay A. Rosenwald, M.D., is the Chairman, President, and CEO of Fortress Biotech, serving on the boards of its public subsidiaries. He has a background in finance and medicine and has been influential in the biotechnology and life sciences sectors for over 25 years.
Lindsay A. Rosenwald, M.D. Company Leadership
Lindsay A. Rosenwald, M.D. currently holds the positions of Chairman, President, and Chief Executive Officer. His leadership roles extend across multiple subsidiaries of Fortress, including Journey Medical, Checkpoint Therapeutics, Avenue Therapeutics, and Mustang Bio. Dr. Rosenwald has played a significant role in steering these companies within the biotechnology and life sciences industry. His influence on these boards underscores his strategic importance in the biotech and pharmaceutical sectors.
Lindsay A. Rosenwald, M.D. Background
Lindsay A. Rosenwald, M.D., has a significant history in the biotechnology and life sciences fields. He served as the Chairman of Paramount BioCapital, Inc. from 1991 to 2008, a tenure marked by his considerable influence within the industry. Over the last 25 years, Dr. Rosenwald has been actively involved in founding and recapitalizing numerous public and private biotechnology and life sciences companies. This extensive experience highlights his long-standing commitment and contributions to the sector.
Lindsay A. Rosenwald, M.D. Education and Expertise
Dr. Lindsay A. Rosenwald received his Bachelor of Science degree in Finance from Pennsylvania State University. He further advanced his academic journey by obtaining an M.D. from Temple University School of Medicine. With a solid foundation in both finance and medicine, Dr. Rosenwald's unique blend of expertise supports his strategic and operational roles in the biotechnology and life sciences industries.
Lindsay A. Rosenwald, M.D. Achievements
Dr. Lindsay A. Rosenwald's notable achievements include his involvement in the founding and recapitalization of various biotechnology and life sciences companies. His tenure as the Chairman of Paramount BioCapital, Inc. from 1991 to 2008 is a testament to his leadership and vision in the industry. These accomplishments emphasize Dr. Rosenwald's instrumental role in advancing the biotechnology and pharmaceutical sectors over the past several decades.